Let’s take a look at the top 10 hybrid scores inside The PPT. I will leave out stocks that trade under 500K shares, as well as Chinese stocks since their financials cannot be trusted (a main ingredient to the hybrid score).
#3 – UTHR: United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of therapeutic products for patients with chronic and life-threatening diseases in the United States and internationally. It offers Remodulin, Tyvaso, and Adcirca for the treatment of pulmonary arterial hypertension (PAH).
#4 – BBD: Banco Bradesco S.A. provides a range of banking and financial products and services to individuals; large, mid-sized, and small companies; and local and international corporations and institutions. It operates in two segments: Banking; and Insurance, Pension, and Capitalization Bonds.
#5 – KLIC: Kulicke and Soffa Industries, Inc. designs, manufactures, and sells capital equipment and expendable tools to assemble semiconductor devices, including integrated circuits, powered discrete devices, light-emitting diodes, and power modules.
#6 – CI: CIGNA Corporation, a health services organization, through its subsidiaries, provides insurance and related products and services in the United States and internationally.
#7 – TRW: TRW Automotive Holdings Corp., together with its subsidiaries, designs, manufactures, and sells automotive systems, modules, and components for automotive original equipment manufacturers (OEM) and related aftermarkets.
#8 – HAL: Halliburton Company provides various products and services to the energy industry for exploring, developing, and producing oil and natural gas worldwide. It operates in two segments, Completion and Production, and Drilling and Evaluation.
#9 PDLI: PDL BioPharma, Inc. engages in intellectual property asset management and royalty bearing assets investment activities. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. It offers Queen et al. patents that cover humanized antibodies, methods for humanizing antibodies, polynucleotide encoding in humanized antibodies, and methods of producing humanized antibodies. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006.
PPT MEMBERS can find the rest of this rankings HERE.